GEN Exclusives

More »

GEN News Highlights

More »
Jun 27, 2011

Phase III Study Shows Ampio Drug Improves Ejaculation Times in Men with PE

  • Ampio Pharmaceuticals reported positive data from a Phase III study evaluating its premature ejaculation candidate Zertane™ in 604 patients. Results from the European trial showed that the lower of two Zertane doses increased the median intravaginal ejaculatory latency time (IELT) by a mean of 4.07 over baseline, and by a geometric mean of 2.3-fold over baseline. The higher dose of Zertane increased mean IELT by 4.26 over baseline, with a geometric mean increase of 2.4-fold over baseline.

    Among men with a median IELT of 1 minute or less at baseline, the results were even more significant. Mean IELT increases were 5.2-fold for the lower dose of Zertane and 6-fold for the higher dose. “We are aggressively pursuing regulatory approval for Zertane in Europe and are in discussions with potential distribution partners in Europe and Asia,” comments Don Wingerter, CEO.

    The firm says no drug has yet been approved in the U.S. specifically for the treatment of premature ejaculation, and clinical data comparisons indicate that Zertane is more effective than dapoxetine (Priligy®), an SSRI antidepressant-type drug that is the only oral drug approved anywhere for the treatment of premature ejaculation.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »